Smoking Cessation and Incident Cardiovascular Disease.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
04 Nov 2024
Historique:
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

The association between smoking cessation and cardiovascular disease (CVD) risk in relation to cumulative smoking exposure remains poorly understood. To evaluate the associations among smoking cessation, lifetime smoking burden, and CVD risk according to the number of years elapsed after smoking cessation. This retrospective cohort study of the Korean National Health Insurance Service database investigated smoking duration and intensity between January 2006 and December 2008. Participants were categorized by self-reported smoking habits as current, ex-, or never-smokers. Smoking records were updated every 2 years until December 2019, with participants whose smoking status changed or whose smoking status was unclear excluded. Data analysis was performed between June and December 2022. Time-updated self-reported smoking status, years since quitting, and cumulative smoking amount (pack-years [PY]). The primary outcome was incidence and hazard ratio of CVD (composite of cardiovascular death, myocardial infarction, stroke, and heart failure). Overall, 5 391 231 participants (39.9% male; mean [SD] age, 45.8 [14.7] years; 853 756 [15.8%] current smokers, 104 604 [1.9%] ex-smokers, and 4 432 871 [82.2%] never smokers) were followed up for a mean (SD) of 4.2 (4.4) years. The median (IQR) baseline cumulative smoking amounts were 14.0 (7.5-20.0) PY in current smokers and 10.5 (5.3-20.0) PY in ex-smokers. The median (IQR) duration of smoking cessation was 4 (2-8) years for ex-smokers. Regardless of continued smoking, a dose-dependent association was evident between smoking and incident CVD. Compared with current smokers, ex-smokers with a lifetime smoking burden of less than 8 PY (light ex-smokers) experienced a significant reduction in CVD risk within 10 years of cessation, with a CVD risk similar to that of never-smokers. Conversely, ex-smokers with at least 8 PY (heavy ex-smokers) exhibited a slower decline in CVD risk than light ex-smokers, requiring more than 25 years for the residual CVD risk to disappear. In this cohort study, smoking and CVD risk exhibited a dose-dependent association, with light ex-smokers having a CVD risk similar to that of never-smokers relatively soon after smoking cessation. For heavy ex-smokers, greater than 25 years might be required for the residual CVD risk to align with that of never-smokers.

Identifiants

pubmed: 39485349
pii: 2825743
doi: 10.1001/jamanetworkopen.2024.42639
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2442639

Auteurs

Jun Hwan Cho (JH)

Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea.
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Seung Yong Shin (SY)

Division of Cardiology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.

Hoseob Kim (H)

Department of Data Science, Hanmi Pharm Co Ltd, Seoul, Republic of Korea.

Mina Kim (M)

Department of Data Science, Hanmi Pharm Co Ltd, Seoul, Republic of Korea.

Kyeongmin Byeon (K)

Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea.
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Moonki Jung (M)

Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea.
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Ki-Woon Kang (KW)

Division of Cardiology, Department of Internal Medicine, Chung-Ang University Hospital College of Medicine, Seoul, Republic of Korea.
Cardiovascular and Arrhythmia Center, Chung-Ang University Hospital, Seoul, Republic of Korea.

Wang-Soo Lee (WS)

Division of Cardiology, Department of Internal Medicine, Chung-Ang University Hospital College of Medicine, Seoul, Republic of Korea.
Cardiovascular and Arrhythmia Center, Chung-Ang University Hospital, Seoul, Republic of Korea.

Sang-Wook Kim (SW)

Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea.
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH